杜尔瓦卢马布:关于有限阶段小细胞肺癌的审查
Nicole L France1, Yahiya Y Syed2
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.
Targeted oncology
|March 13, 2026
概括
杜尔瓦卢马布免疫疗法显著改善了有限阶段小细胞肺癌患者在化疗和放射后的生存率. 这种整合性治疗为这些患者提供了新的护理标准.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床试验 临床试验
背景情况:
- 杜尔瓦卢马布是一种单克隆抗体,向PD-L1.1.
- 它是第一个被批准用于有限阶段小细胞肺癌 (LS-SCLC) 的免疫疗法.
- 关于并发化疗或放射治疗 (cCRT) 要求的批准有所不同.
研究的目的:
- 在LS-SCLC患者中评估巩固杜瓦卢马布的疗效和安全性.
- 确立杜尔瓦卢马布作为潜在的新标准护理.
主要方法:
- 第三阶段的ADRIATIC试验.
- 巩固静脉注射杜尔瓦卢马布 (每周4次,长达24个月) 与安慰剂.
- 患有LS-SCLC的患者,他们的疾病在cCRT后没有进展.
主要成果:
- 与安慰剂相比,杜尔瓦卢马布显著改善了整体存活率和无进展存活率.
- 无论之前的cCRT组件或预防性头骨辐射,都观察到好处.
- 杜尔瓦卢马布表现出可管理的耐受性和安全性.
结论:
- 巩固杜瓦卢马布代表了在cCRT后对LS-SCLC患者的新标准护理.
- 阿德里亚特克试验提供了强有力的证据支持其使用.
- 杜尔瓦卢马布在这个患者群体中提供了显著的生存益处.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.4K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
6.0K
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
